Arkolith/Insider Trading/RNAZ/Form 4

Dudley Robert Michael

Chief Executive Officer, Director, 10% OwnerTranscode Therapeutics, Inc. (RNAZ) · full profile →Form 4 · filed Jun 1, 2022
Net Buying
Open-Market Buys
$55K
Open-Market Sells
$0
Net Open-Market Flow
$55K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 31, 2022Buy(P)2K$1.87$4K873K
May 27, 2022Buy(P)28K$1.84$52K871K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-067099) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML